Lymphoma News and Research

RSS

Lymphoma is cancer that begins in cells of the immune system. There are two basic categories of lymphomas. One kind is Hodgkin lymphoma, which is marked by the presence of a type of cell called the Reed-Sternberg cell. The other category is non-Hodgkin lymphomas, which includes a large, diverse group of cancers of immune system cells. Non-Hodgkin lymphomas can be further divided into cancers that have an indolent (slow-growing) course and those that have an aggressive (fast-growing) course. These subtypes behave and respond to treatment differently. Both Hodgkin and non-Hodgkin lymphomas can occur in children and adults, and prognosis and treatment depend on the stage and the type of cancer.

TET proteins help regulate gene activity vital for normal antibody production

A family of cancer suppressive proteins, known as TET proteins, help regulate gene activity via their influence on chromosomal architecture. However, until now it wasn't entirely clear how genes were activated by TET proteins to make sure that cells perform their normal functions efficiently.

27 Apr 2019

Johns Hopkins researchers uncover role of neurotransmitter in the spread of aggressive cancers

Using human cancer cells, tumor and blood samples from cancer patients, researchers at Johns Hopkins Medicine have uncovered the role of a neurotransmitter in the spread of aggressive cancers. Neurotransmitters are chemical "messengers" that transmit impulses from neurons to other target cells.

25 Apr 2019

Researchers define role of rare, influential cells in the bone marrow

Researchers have defined the roles of various cells in the bone marrow that are thought to control the fate of the nearly half million blood cells that develop there each day.

23 Apr 2019

Novel ECCITE-seq technique expands multimodal single cell analysis

A new technique called ECCITE-seq, developed by scientists at the New York Genome Center's Technology Innovation Lab, allows researchers to perform high-throughput measurements of multiple modalities of information from single cells.

From 10x Genomics, Inc. 23 Apr 2019

Advance in breakthrough cancer treatment eliminates serious side effects

An advance in the breakthrough cancer treatment known as CAR T-cell therapy appears to eliminate its severe side effects, making the treatment safer and potentially available in outpatient settings, a new USC study shows.

22 Apr 2019

Overlooked part of cell’s internal machinery may hold key to treating acute myeloid leukemia

Many individuals forced to fight an exceptionally aggressive form of the blood cancer acute myeloid leukemia (AML) don't survive more than five years.

22 Apr 2019

Research sheds light on how leukemia cells become resistant to drugs

Three children Alejandro Gutierrez, MD, treated for leukemia during his fellowship at Boston Children's Hospital still haunt him more than a decade later.

17 Apr 2019

Meta-analysis of glyphosate-based plant protection products and NHL involves uncertainty

In the meta-analysis, Luoping Zhang, University of California, Berkeley, and her team pursued the question of whether people who used plant protection products containing glyphosate had an increased risk of contracting Non-Hodgkin Lymphoma, a form of lymph node cancer.

15 Apr 2019

Researchers discover unique approach to treat some chronic inflammatory diseases

Inflammation is a balanced physiological response -- the body needs it to eliminate invasive organisms and foreign irritants, but excessive inflammation can harm healthy cells, contributing to aging and chronic diseases.

12 Apr 2019

German Research Foundation recently approves new research unit

"Cytomegalovirus, beware of this new research group!" This could be the motto of a new research unit recently approved by the German Research Foundation. It is titled: "Advanced concepts in cellular control of cytomegalovirus ".

11 Apr 2019

Large-scale screen efficiently identifies drugs that are potent cancer-killers

UC San Francisco scientists have designed a large-scale screen that efficiently identifies drugs that are potent cancer-killers when combined, but only weakly effective when used alone.

10 Apr 2019

‘Hit-and-run’ interaction between proteins appears to be key trigger for cell death

A 'hit-and-run' interaction between two proteins could be an important trigger for cell death, according to new research from Walter and Eliza Hall Institute researchers.

10 Apr 2019

Cancer vaccine injected into tumour could kill all cancer cells

Researchers have developed an experimental cancer vaccine that when injected into a single tumour can help trigger the immune system to kill the cancer cells circulating within the body. The results of the study titled, “Systemic clinical tumor regressions and potentiation of PD1 blockade with in situ vaccination,” were published in the latest issue of the journal Nature Medicine, this week, Monday.

9 Apr 2019

Scientists visualize immune cells fighting blood cancer for the first time

When cancer escapes the immune system, our defenses are rendered powerless and are unable to fight against the disease.

8 Apr 2019

Study finds no statistically significant effect of drug shortages on cancer treatment

For the vast majority of cancer drugs experiencing shortages over a seven-year period, a new USC research study found no statistically significant effect of shortages on chemotherapy treatment.

8 Apr 2019

ASCO issues guideline recommending older adults with cancer to receive geriatric assessment

Although the majority of patients who have blood cancers are older adults, they make up only a small percentage of participants in the clinical trials that lead to new therapies.

8 Apr 2019

Popular weed killer’s alleged link to cancer spreads concern

Clumps of dandelions have popped up in your yard, so you reach for a bottle of Roundup, the popular weed killer. It is known for being very effective, but its main ingredient, glyphosate, is getting a lot of attention because of lawsuits alleging links to cancer.

4 Apr 2019

Lymphoma News and Research

Further Reading

TET proteins help regulate gene activity vital for normal antibody production

Johns Hopkins researchers uncover role of neurotransmitter in the spread of aggressive cancers

Researchers define role of rare, influential cells in the bone marrow

Novel ECCITE-seq technique expands multimodal single cell analysis

Advance in breakthrough cancer treatment eliminates serious side effects

Overlooked part of cell’s internal machinery may hold key to treating acute myeloid leukemia

Research sheds light on how leukemia cells become resistant to drugs

Meta-analysis of glyphosate-based plant protection products and NHL involves uncertainty

Researchers discover unique approach to treat some chronic inflammatory diseases

German Research Foundation recently approves new research unit

Large-scale screen efficiently identifies drugs that are potent cancer-killers

‘Hit-and-run’ interaction between proteins appears to be key trigger for cell death

Cancer vaccine injected into tumour could kill all cancer cells

Scientists visualize immune cells fighting blood cancer for the first time

Study finds no statistically significant effect of drug shortages on cancer treatment

ASCO issues guideline recommending older adults with cancer to receive geriatric assessment

Popular weed killer’s alleged link to cancer spreads concern

Dogs with hypothyroidism or that take omega-3 fatty acid may have lower risk of T-zone lymphoma

HCA Healthcare UK introduces ground-breaking new blood cancer treatment

Study reveals investigational drug as effective treatment for relapsed marginal zone lymphoma

Everything you should know about lymphoma eBook

Bringing real-time analytics to downstream bioprocess monitoring

Designing fluidic architecture for scalable diagnostic platforms

Evaluating new approaches for rare disease genomics

Latest News